Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cerilliant
Medtronic
Teva
Farmers Insurance
Fuji
Baxter
Queensland Health
Deloitte

Generated: April 26, 2018

DrugPatentWatch Database Preview

SOTYLIZE Drug Profile

« Back to Dashboard

Which patents cover Sotylize, and what generic alternatives are available?

Sotylize is a drug marketed by Arbor Pharms Llc and is included in one NDA. There is one patent protecting this drug.

This drug has one patent family member in one country.

The generic ingredient in SOTYLIZE is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.
Summary for SOTYLIZE
Drug patent expirations by year for SOTYLIZE
Pharmacology for SOTYLIZE
Drug ClassAntiarrhythmic
Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectCardiac Rhythm Alteration
Medical Subject Heading (MeSH) Categories for SOTYLIZE
Synonyms for SOTYLIZE
( inverted question mark)-Sotalol hydrochloride
(?)-Sotalol hydrochloride
(+)-Sotalol hydrochloride
(+/-)-Sotalol hydrochloride
(+/-)-Sotalol hydrochloride, >=98% (TLC), powder
(+/-)-Sotalol hydrochloride, analytical standard
(y)-Sotalol hydrochloride
[(Isopropylamino)hydroxyethyl]methanesulfonanilide hydrochloride
3930-20-9 (Parent)
4 inverted exclamation mark -(1-hydroxy-2-(isopropylamino)ethyl)-methanesulfonanilidmonohydrochlorid
4 inverted exclamation mark -(1-hydroxy-2-(isopropylamino)ethyl)methanesulfonanilidemonohydrochloride
4-(2-Isopropylamino-1-hydroxyaethyl)methanesulfonailid hydrochlorid
4-(2-Isopropylamino-1-hydroxyaethyl)methanesulfonailid hydrochlorid [German]
4-(2-isopropylamino-1-hydroxyaethyl)methanesulfonailidhydrochlorid
4-[2-(Isopropylamine)-1-hydroxyethyl]methanesulfonanilide hydrochloride
4'-(1-Hydroxy-2-(isopropylamino)ethyl)methanesulfonanilide monohydrochloride
4'-(1-Hydroxy-2-isopropylaminoethyl)methanesulphonanilide hydrochloride
4'-[1-Hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide hydrochloride
4'-[1-Hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide monohydrochloride
4'-[2-(Isopropylamino)-1-hydroxyethyl]methanesulfonanilide hydrochloride
4'-[2-(Isopropylamino)-1-hydroxyethyl]methanesulfonanilide monohydrochloride
959-24-0
959S240
A845501
AB0012836
AB2000612
AC-3541
AC1L24Y9
AC1Q394B
AK162384
AKOS015888287
AN-12879
AN-19653
API0006283
AS-13017
AX8089585
BC209131
BCP0726000245
Berlex
Berlex Laboratories
Betapace
Betapace (TN)
Betapace AF
Betapace AF;Berlex Laboratories;Sotalex;Betapace
BG0406
C12H20N2O3S.HCl
C12H21ClN2O3S
CAS-959-24-0
CCG-100907
CCG-213603
CHEBI:9207
CHEMBL1700
CPD000326828
CS-2543
CTK8G3175
D01026
DSSTox_CID_1278
DSSTox_GSID_21278
DSSTox_RID_76054
DTXSID8021278
EINECS 213-496-0
EU-0101055
FT-0603531
HMS1571A13
HY-B0437
I01-1040
Isopropylaminohydroxyethylmethanesulfonanilide hydrochloride
isopropylaminohydroxyethylmethanesulfonanilidehydrochloride
J10044
KM3383
KS-000011O8
LP01055
LS-7704
Mead johnson 1999
meadjohnson1999
Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-, monohydrochloride
Methanesulfonanilide, 4'-(1-hydroxy-2-(isopropylamino)ethyl)-, monohydrochloride
MFCD00242937
MJ 1999
MJ 1999 hydrochloride
MLS000758296
MLS000859969
MLS001401380
MLS002222318
MolPort-003-959-478
N-(2-hydroxy-2-{4-[(methylsulfonyl)amino]phenyl}ethyl)propan-2-aminium chloride
N-(4-(1-hydroxy-2-(isopropylamino)ethyl)phenyl)methanesulfonamide hydrochloride
N-(4-[1-Hydroxy-2-(isopropylamino)ethyl]phenyl)methanesulfonamide hydrochloride
N-(4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}phenyl)methanesulfonamide hydrochloride
N-(4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}phenyl)methanesulfonamide hydrochloride
N-[4-[1-Hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide hydrochloride
N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide hydrochloride
N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide;hydrochloride
N-[4-[1-Hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]methanesulfonamide hydrochloride
N-[4-[1-oxidanyl-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide hydrochloride
N-{4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl}methanesulfonamide hydrochloride
N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide hydrochloride
N-Isopropyl-.beta.-(4-methanesulfonamidophenyl)ethanolamine hydrochloride
N-Isopropyl-beta-(4-methanesulfonamidophenyl)ethanolamine hydrochloride
n-isopropyl-beta-(4-methanesulfonamidophenyl)ethanolaminehydrochloride
NC00157
NCGC00094337-01
NCGC00094337-02
NCGC00094337-03
NCGC00257681-01
NCGC00261740-01
NSC-337251
NSC-760358
NSC337251
NSC760358
OR162367
p-[1-Hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide hydrochloride
Pharmakon1600-01506043
Q-201730
S 0278
s2509
SAM001246725
SAM001246990
SBB063265
SC-13317
SCHEMBL118761
SMR000326828
Sorine
Sorine (TN)
Sotacor
Sotalex
Sotalol (Betapace)
Sotalol (hydrochloride)
Sotalol HCL
Sotalol hydrochloride
Sotalol hydrochloride (JAN/USP)
Sotalol hydrochloride [USAN:USP]
Sotalol hydrochloride [USAN]
Sotalol Hydrochloride 1.0 mg/ml in Methanol (as free base)
Sotalol hydrochloride, United States Pharmacopeia (USP) Reference Standard
Sotalol Monohydrochloride
Sotalol.HCl
ST24049297
Tox21_111267
Tox21_200127
Tox21_501055
VIDRYROWYFWGSY-UHFFFAOYSA-N
WLN: WS1&MR DYQ1MY1&1 &GH

US Patents and Regulatory Information for SOTYLIZE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc SOTYLIZE sotalol hydrochloride SOLUTION;ORAL 205108-001 Oct 22, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
QuintilesIMS
Cipla
Teva
Boehringer Ingelheim
Queensland Health
Daiichi Sankyo
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.